IBONYSEPharmaceutical PreparationsFiscal year ends December 31
IMPACT BIOMEDICAL INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026
- Market cap
- $329.93M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Impact Biomedical has not reported a dividend
No dividend per share appears in Impact Biomedical's annual filings since fiscal 2022.